Predicting MRONJ Recurrence: Key Risk Factors in Cancer Patients on Antiresorptive Therapy
Abstract Antiresorptive therapies, widely used in oncology for bone metastases, are associated with medication-related osteonecrosis of the jaw (MRONJ) a condition with significant clinical and public health implications. This study investigates recurrence rates and risk factors for MRONJ in cancer patients, aiming t...